JPWO2020130103A1 - カウンセリング方法及びカウンセリング装置 - Google Patents
カウンセリング方法及びカウンセリング装置 Download PDFInfo
- Publication number
- JPWO2020130103A1 JPWO2020130103A1 JP2020561526A JP2020561526A JPWO2020130103A1 JP WO2020130103 A1 JPWO2020130103 A1 JP WO2020130103A1 JP 2020561526 A JP2020561526 A JP 2020561526A JP 2020561526 A JP2020561526 A JP 2020561526A JP WO2020130103 A1 JPWO2020130103 A1 JP WO2020130103A1
- Authority
- JP
- Japan
- Prior art keywords
- skin
- information
- user
- counseling
- stratum corneum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009223 counseling Methods 0.000 title claims abstract description 144
- 238000000034 method Methods 0.000 title claims abstract description 54
- 210000003491 skin Anatomy 0.000 claims abstract description 654
- 230000002068 genetic effect Effects 0.000 claims abstract description 150
- 210000000434 stratum corneum Anatomy 0.000 claims abstract description 129
- 239000002537 cosmetic Substances 0.000 claims abstract description 125
- 238000012360 testing method Methods 0.000 claims abstract description 63
- 238000007689 inspection Methods 0.000 claims description 34
- 238000004364 calculation method Methods 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 description 61
- 230000037303 wrinkles Effects 0.000 description 51
- 230000007246 mechanism Effects 0.000 description 32
- 230000009471 action Effects 0.000 description 26
- 238000004891 communication Methods 0.000 description 26
- 238000012545 processing Methods 0.000 description 24
- 238000010586 diagram Methods 0.000 description 19
- 230000004888 barrier function Effects 0.000 description 14
- 230000005540 biological transmission Effects 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 206010042496 Sunburn Diseases 0.000 description 10
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 230000006866 deterioration Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 230000003796 beauty Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 102000009634 interleukin-1 receptor antagonist activity proteins Human genes 0.000 description 4
- 108040001669 interleukin-1 receptor antagonist activity proteins Proteins 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 230000019612 pigmentation Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 102000012422 Collagen Type I Human genes 0.000 description 3
- 108010022452 Collagen Type I Proteins 0.000 description 3
- 101000642478 Homo sapiens Serpin B3 Proteins 0.000 description 3
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 3
- 102100036383 Serpin B3 Human genes 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008092 positive effect Effects 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000010485 coping Effects 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 230000036548 skin texture Effects 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 102100037129 ATP-binding cassette sub-family C member 11 Human genes 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 101001029057 Homo sapiens ATP-binding cassette sub-family C member 11 Proteins 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/01—Social networking
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/005—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms for selecting or displaying personal cosmetic colours or hairstyle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0077—Devices for viewing the surface of the body, e.g. camera, magnifying lens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/06—Buying, selling or leasing transactions
- G06Q30/0601—Electronic shopping [e-shopping]
- G06Q30/0631—Item recommendations
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D2044/007—Devices for determining the condition of hair or skin or for selecting the appropriate cosmetic or hair treatment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Business, Economics & Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Primary Health Care (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Theoretical Computer Science (AREA)
- General Business, Economics & Management (AREA)
- Strategic Management (AREA)
- Marketing (AREA)
- Economics (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Finance (AREA)
- Accounting & Taxation (AREA)
- Tourism & Hospitality (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Data Mining & Analysis (AREA)
- Human Resources & Organizations (AREA)
- Dermatology (AREA)
- Development Economics (AREA)
- Chemical & Material Sciences (AREA)
- Databases & Information Systems (AREA)
- Computing Systems (AREA)
- Bioinformatics & Computational Biology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
Abstract
Description
上述した実施例では、特定部354は、肌体質によって遺伝的特徴に基づくリスクが高いと示され、且つ、肌の能力によって外的及び内的リスクが高いと示された肌特性に応じたスキンケアアドバイス及び化粧品を特定したが、これに限られない。特定部354は、肌の能力に基づいて外的及び内的リスクが高い肌特性を特定し、肌体質に基づいて肌特性の悪化のメカニズムを特定し、特定された肌特性とメカニズムとに基づいてスキンケアアドバイス及び/又は化粧品を特定してもよい。
カウンセリング装置3において、特定部354は、肌体質に基づいて第1化粧品を特定し、肌の能力に基づいて第2化粧品を特定してもよい。例えば、特定部354は、肌体質によって遺伝的特徴に基づくリスクが高いと示されている肌特性に応じて第1化粧品を特定する。また、特定部354は、肌の能力によって外的及び内的リスクが高いと示されている肌特性に応じて第2化粧品を特定する。提示部355は、特定された第1化粧品の情報と第2化粧品の情報とを含むカウンセリング情報をユーザに提示する。このような構成を備えることにより、カウンセリング装置3は、ユーザの肌に現在生じている問題とユーザの肌に将来生じうる問題とに対処するための、ユーザの肌にとって長期的な視点で適切な化粧品を提示することを可能とする。
カウンセリング装置3において、取得部351は、ユーザの問診情報を取得し、特定部354は、問診情報にさらに基づいて、ユーザに提示する化粧品を特定してもよい。
カウンセリング装置3において、角層情報は、取得時期が異なる複数の角層検査の結果を含み、肌の能力判定部353は、角層情報に基づいて肌の能力の変動パターンを判定してもよい。
カウンセリング装置3において、取得部351は、ユーザの肌を撮影した肌画像に基づく肌画像情報を取得し、特定部354は、肌画像情報にさらに基づいて、スキンケアアドバイス及び化粧品を特定してもよい。
また、カウンセリング装置3において、取得部351は、ユーザの属性情報又は嗜好情報と、ユーザの肌を撮影した肌画像に基づく肌画像情報とをさらに取得してよい。そして、特定部354は、肌の能力、属性情報又は嗜好情報、及び、肌画像情報に基づいて、ユーザの肌に影響する要素を抽出し、肌体質と抽出された要素とに基づいて、スキンケアアドバイス及び化粧品を特定してよい。
なお、上述した説明では、カウンセリング装置3において、特定部354は、肌体質情報及び肌の能力情報に基づいて肌特性を特定し、特定された肌特性に基づいてスキンケアアドバイス及び化粧品を特定したが、これに限られない。特定部354は、肌体質情報に代えて、遺伝子情報に基づいてスキンケアアドバイス及び/又は化粧品を特定してよい。
また、カウンセリング装置3において、提示部355が提示するカウンセリング情報は、ユーザが自身と近い肌体質をもつ他のユーザと情報を交換し、又はスキンケアアドバイス及び化粧品に関する情報を得るためのコミュニティに関する情報を含んでもよい。
1 遺伝子検査装置
2 角層検査装置
3 カウンセリング装置
31 記憶部
32 操作部
33 表示部
34 通信部
35 処理部
351 取得部
352 肌体質判定部
353 肌の能力判定部
354 特定部
355 提示部
Claims (9)
- ユーザの遺伝子検査の結果を表す遺伝子情報と、前記ユーザの角層検査の結果を表す角層情報とを取得し、
前記遺伝子情報に基づいて前記ユーザの肌体質を判定し、
前記角層情報に基づいて前記ユーザの肌の能力を判定し、
前記肌体質と前記肌の能力とに基づいて前記ユーザに提案するスキンケアアドバイス及び/又は化粧品を特定し、
前記特定されたスキンケアアドバイス及び/又は化粧品の情報を含むカウンセリング情報を前記ユーザに提示する、
ことを含むカウンセリング方法。 - 前記カウンセリング情報は、前記肌体質の情報と前記肌の能力の情報とを含む、
請求項1に記載のカウンセリング方法。 - 前記ユーザの属性情報又は嗜好情報を取得する、
ことを含み、
前記スキンケアアドバイス及び/又は化粧品を特定することは、前記属性情報又は嗜好情報にさらに基づく、
請求項1又は2に記載のカウンセリング方法。 - 前記角層情報は、取得時期が異なる複数の角層検査の結果を含み、
前記肌の能力を判定することは、前記角層情報に基づいて肌の能力の変動パターンを判定することを含む、
請求項1〜3の何れか一項に記載のカウンセリング方法。 - 前記ユーザの肌を撮影した肌画像に基づく肌画像情報を取得する、
ことを含み、
前記スキンケアアドバイス及び/又は化粧品を特定することは、前記肌画像情報にさらに基づく、
請求項1〜4の何れか一項に記載のカウンセリング方法。 - 前記ユーザの属性情報又は嗜好情報と、前記ユーザの肌を撮影した肌画像に基づく肌画像情報とを取得する、
ことをさらに含み、
前記スキンケアアドバイス及び/又は化粧品を特定することは、
前記肌の能力と前記属性情報又は嗜好情報と前記肌画像情報とに基づいて、前記ユーザの肌に影響する要素を抽出し、
前記肌体質と前記抽出された要素とに基づいて、スキンケアアドバイス及び/又は化粧品を特定することを含む、
請求項1〜5の何れか一項に記載のカウンセリング方法。 - 前記カウンセリング情報は、ユーザが他のユーザと情報を交換し、又はスキンケアアドバイス及び/又は化粧品に関する情報を得るためのコミュニティに関する情報を含む、請求項1〜6の何れか一項に記載のカウンセリング方法。
- 前記カウンセリング情報は、肌の安定度に関する情報を含む、請求項1〜7の何れか一項に記載のカウンセリング方法。
- ユーザの遺伝子検査の結果を表す遺伝子情報と、前記ユーザの角層検査の結果を表す角層情報とを取得する取得部と、
前記遺伝子情報に基づいて前記ユーザの肌体質を判定する肌体質判定部と、
前記角層情報に基づいて前記ユーザの肌の能力を判定する肌の能力判定部と、
前記肌体質と前記肌の能力とに基づいて前記ユーザに提案するスキンケアアドバイス及び/又は化粧品を特定する特定部と、
前記特定されたスキンケアアドバイス及び/又は化粧品の情報を含むカウンセリング情報を前記ユーザに提示する提示部と、
を備えるカウンセリング装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018240364 | 2018-12-21 | ||
JP2018240364 | 2018-12-21 | ||
PCT/JP2019/049942 WO2020130103A1 (ja) | 2018-12-21 | 2019-12-19 | カウンセリング方法及びカウンセリング装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2020130103A1 true JPWO2020130103A1 (ja) | 2021-11-18 |
JP7563983B2 JP7563983B2 (ja) | 2024-10-08 |
Family
ID=71101194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020561526A Active JP7563983B2 (ja) | 2018-12-21 | 2019-12-19 | カウンセリング方法及びカウンセリング装置 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220051806A1 (ja) |
JP (1) | JP7563983B2 (ja) |
CN (1) | CN113228088A (ja) |
WO (1) | WO2020130103A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7121876B1 (ja) * | 2021-12-07 | 2022-08-18 | マルホ株式会社 | 情報処理装置及びコンピュータプログラム |
JP7397265B2 (ja) * | 2022-04-06 | 2023-12-13 | 株式会社プラチナファーマ | サプリメント評価装置およびサプリメント評価方法 |
JP2024053456A (ja) * | 2022-10-03 | 2024-04-15 | 花王株式会社 | 情報処理システム及び情報処理方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002056281A (ja) * | 2000-08-09 | 2002-02-20 | Pola Chem Ind Inc | 肌の改善の為のアドバイスの選択方法及びその表示方法 |
JP2010515489A (ja) * | 2007-01-05 | 2010-05-13 | マイスキン インコーポレイテッド | 皮膚を撮像するためのシステム、装置、及び方法 |
WO2012172625A1 (ja) * | 2011-06-13 | 2012-12-20 | 株式会社洛洛.Com | 美容snsシステム及びプログラム |
JP2016077649A (ja) * | 2014-10-18 | 2016-05-16 | 井上 賢一 | 画像処理技術を用いた被検者の肌または頭皮状態の判定システム及びそのビジネス方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2538841A2 (en) * | 2010-02-26 | 2013-01-02 | Myskin, Inc. | Analytic methods of tissue evaluation |
US20150045631A1 (en) * | 2013-03-15 | 2015-02-12 | Lee Pederson | Skin health system |
CA2921704A1 (en) | 2013-09-25 | 2015-04-02 | The Procter & Gamble Company | Method and system for skin care consultation |
US20160335910A1 (en) * | 2015-05-15 | 2016-11-17 | Metabeauty, Inc. | Comprehensive Skincare Treatment Plan To Change Skin Type |
TW201825685A (zh) | 2016-11-30 | 2018-07-16 | 日商資生堂股份有限公司 | 肌膚特性解析方法 |
CN109003673A (zh) * | 2017-06-05 | 2018-12-14 | 新加坡北斗多维养生公司 | 一种推荐适于个体的活性成分和护肤品的方法以及护肤方法 |
CN107977549B (zh) * | 2017-12-06 | 2021-04-13 | 懿奈(上海)生物科技有限公司 | 一种基于皮肤多组学的护肤匹配方法及终端 |
-
2019
- 2019-12-19 JP JP2020561526A patent/JP7563983B2/ja active Active
- 2019-12-19 US US17/414,519 patent/US20220051806A1/en active Pending
- 2019-12-19 WO PCT/JP2019/049942 patent/WO2020130103A1/ja active Application Filing
- 2019-12-19 CN CN201980084469.9A patent/CN113228088A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002056281A (ja) * | 2000-08-09 | 2002-02-20 | Pola Chem Ind Inc | 肌の改善の為のアドバイスの選択方法及びその表示方法 |
JP2010515489A (ja) * | 2007-01-05 | 2010-05-13 | マイスキン インコーポレイテッド | 皮膚を撮像するためのシステム、装置、及び方法 |
WO2012172625A1 (ja) * | 2011-06-13 | 2012-12-20 | 株式会社洛洛.Com | 美容snsシステム及びプログラム |
JP2016077649A (ja) * | 2014-10-18 | 2016-05-16 | 井上 賢一 | 画像処理技術を用いた被検者の肌または頭皮状態の判定システム及びそのビジネス方法 |
Also Published As
Publication number | Publication date |
---|---|
US20220051806A1 (en) | 2022-02-17 |
CN113228088A (zh) | 2021-08-06 |
WO2020130103A1 (ja) | 2020-06-25 |
JP7563983B2 (ja) | 2024-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yan et al. | Design of a breath analysis system for diabetes screening and blood glucose level prediction | |
Longbottom et al. | Electrical measurements for use in caries clinical trials | |
JP7563983B2 (ja) | カウンセリング方法及びカウンセリング装置 | |
Collins et al. | Reliability of the Semmes Weinstein Monofilaments to measure coetaneous sensibility in the feet of healthy subjects | |
Jung et al. | Wrist-wearable bioelectrical impedance analyzer with miniature electrodes for daily obesity management | |
JP5400217B2 (ja) | 伝統中国医学(tcm)の原理に基づいて肌組成を判定するコンピュータ援用診断システム | |
JP7015795B2 (ja) | 体状態の分類 | |
Amin et al. | The psychological impact of facial changes in scleroderma | |
WO2013066642A1 (en) | Automated personal medical diagnostic system, method, and arrangement | |
JP2005228315A (ja) | 児童成長発育管理システム及び方法 | |
Lee et al. | Clinical utility of the modified trunk impairment scale for stroke survivors | |
US20220357279A1 (en) | Dual wavelength combined fingerprint and high wavenumber raman spectroscopy and applications of same | |
Basjaruddin et al. | Measurement device for stress level and vital sign based on sensor fusion | |
Liden et al. | Accuracy and reliability of the SenseWear™ armband as an energy expenditure assessment device | |
Stoner et al. | Reliability of pulse waveform separation analysis responses to an orthostatic challenge | |
CN114207726A (zh) | 实现肌肤咨询的基因检查方法 | |
Chittawatanarat et al. | The variations of body mass index and body fat in adult Thai people across the age spectrum measured by bioelectrical impedance analysis | |
Soke et al. | Reliability and validity of the timed 360 turn test in people with multiple sclerosis | |
Pierleoni et al. | Biological age estimation using an eHealth system based on wearable sensors | |
Pierleoni et al. | A non-invasive method for biological age estimation using frailty phenotype assessment | |
Muñoz Esquivel et al. | Factors influencing continued wearable device use in older adult populations: quantitative study | |
Almeida et al. | Protocol for a prospective cohort study on the feasibility of application of nutritional ultrasound in the diagnosis and follow-up of patients with nutritional risk at hospital discharge: study on body composition and function (DRECO) | |
Hughes et al. | Social support reduces resting cardiovascular function in women | |
TW201006436A (en) | Detecting device, analysis device and detecting method for autonomic nerve state | |
JP7572188B2 (ja) | ストレス耐性の判定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221019 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231212 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240213 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240806 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20240814 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240917 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240926 |